[DOI] [PubMed] [Google Scholar] 147.Carboni L., Rullo L., Caputi F.F., Stamatakos S., Candeletti S., Romualdi P
Cannula technique is also acceptable for less precision-critical applications
Neither BPC-157 nor GHK-Cu exists as FDA-approved prescription medications, making cost comparison unique to the compounded peptide market
Limited intervention studies (highlighted in 8) have not convincingly demonstrated a potential anti-inflammatory effect of -tocopherol in humans
Extensive pre-clinic studies and clinical trials also are required for proving the druggable potential of these targets
Evidence summary by indication Oxaliplatin-induced peripheral neuropathy prevention (chemotherapy) Design and dose: Randomized, double-blind, placebo-controlled trial in advanced colorectal cancer